Skip to main content

Editas Medicine, Inc 10-Q for FY2024 Q2

Editas Medicine, Inc. (EDIT)

10-Q 2024-08-07 For: 2024-06-30
View Original
Added on April 10, 2026

About this 10-Q

Editas Medicine, Inc filed this 10-Q on August 7, 2024, covering the quarter ended June 30, 2024 (FY2024 Q2).

Headline figures

Quarter ended June 30, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$513K
down 82.2% from $2.89M a year earlier
Net loss
$67.61M
compared with a net loss of $40.29M a year earlier
Diluted EPS
-$0.82
compared with -$0.56 a year earlier